Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02846376
Title Single Agent and Combined Inhibition After Allogeneic Stem Cell Transplant (CPIT-002)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Hackensack University Medical Center
Indications

acute myeloid leukemia

myelodysplastic syndrome

Therapies

Ipilimumab

Ipilimumab + Nivolumab

Nivolumab

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST